Skip to main content
. 2010 Dec 20;5(12):e15344. doi: 10.1371/journal.pone.0015344

Figure 2. The depolarizing sag in ipRGCs and its mediation by I h.

Figure 2

AD) Analysis of the hyperpolarizations evoked in ipRGCs by current injections of 0, 10, 20, 40 and 60 pA (500 ms). For larger current steps, membrane potential sagged from its peak hyperpolarization back toward resting potential (Panels A and C; ‘Control’). A) Depolarizing sag in an example cell (top) and its blockade (bottom) by bath application of the I h blocker ZD7288 (100 µM). B) Current-voltage plots of data in A drawn from the end of the current pulse, at the time marked by symbols in A (squares: control conditions; triangles: in presence of drug). Input resistance (RN), calculated as the slope of the linear fit to these current-voltage data, was increased by the I h antagonist. C, D) Extracellular Cs+ (3 mM), an alternative I h blocker, reproduced the effects of ZD7288 in another ipRGC, blocking the depolarizing sag (C) and increasing RN (D). Resting potential was maintained at 72 mV in both this cell and that in A (see methods). E, F) Group data showing that both ZD7288 and Cs+ dramatically attenuate the depolarizing sag (E; measured as the peak-to-steady state potential difference during 60 pA current injections) and increase RN (F; measured as in B and D). * P<0.05.